Join/Renew

ACEP ID:

Reversal of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in the Presence of Major Life-Threatening Bleeding

Reaffirmed January 2024, February 2023

Originally approved June 2017

Download the Policy

PDF Icon Reversal of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in the Presence of Major Life-Threatening Bleeding February 2024
[ Feedback → ]